|
J Biol Chem, Vol. 275, Issue 8, 5860-5866, February 25, 2000
The Insulin-like Growth Factors (IGFs) I and II Bind to Articular
Cartilage via the IGF-binding Proteins*
Nirav R.
Bhakta ,
A. Minerva
Garcia ,
Eliot H.
Frank ,
Alan J.
Grodzinsky , and
Teresa I.
Morales §¶
From the Center for Biomedical Engineering and
Department of Electrical Engineering and Computer Science,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 and the § Department of Orthopaedic Surgery, Massachusetts
General Hospital and Harvard Medical School,
Boston, Massachusetts 02114
Bovine articular cartilage discs (3 mm
diameter × 400 µm thick) were equilibrated in buffer containing
125I-insulin-like growth factor (IGF)-I
(4 °C) ± unlabeled IGF-I or IGF-II. Competition for binding to
cartilage discs by each unlabeled IGF was
concentration-dependent, with ED50 values for inhibition of 125I-IGF-I binding of 11 and 10 nM for IGF-I and -II, respectively, and saturation by 50 nM. By contrast, an analog of IGF-I with very low affinity
for the insulin-like growth factor-binding proteins (IGF-BPs),
des-(1-3)-IGF-I, was not competitive with 125I-IGF-I for
cartilage binding even at 100-400 nM. Binding of the 125I-labeled IGF-II isoform to cartilage was competed for
by unlabeled IGF-I or -II, with ED50s of 160 and 8 nM, respectively. This probably reflected the differential
affinities of the endogenous IGF-BPs (IGF-BP-6 and -2) for
IGF-II/IGF-I. Transport of 125I-IGF-I was also measured in
an apparatus that allows diffusion only across the discs (400 µm), by
addition to one side and continuous monitoring of efflux on the other
side. The time lag for transport of 125I-IGF was 266 min,
an order of magnitude longer than the theoretical prediction for free
diffusion in the matrix. 125I-IGF-I transport then reached
a steady state rate (% efflux of total added 125I-IGF/unit
time), which was subsequently accelerated ~2-fold by addition of an
excess of unlabeled IGF-I. Taken together, these results indicate that
IGF binding to cartilage, mostly through the IGF-BPs, regulates the
transport of IGFs in articular cartilage, probably contributing to the
control of their paracrine activities.
*
This work was supported by a supplemental award to National
Institutes of Health Grant R01 AR33236 and by the Center for Biomedical Engineering (Massachusetts Institute of Technology, Cambridge, MA).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Orthopaedic Surgery, White Bldg. R426, Massachusetts General Hospital, Boston, MA 02114. Tel.: 617-724-7397; Fax: 617-724-7396; E-mail: tmorales@partners.org.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Tokunou, R. Miller, P. Patwari, M. E. Davis, V. F. M. Segers, A. J. Grodzinsky, and R. T. Lee
Engineering insulin-like growth factor-1 for local delivery
FASEB J,
June 1, 2008;
22(6):
1886 - 1893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dubaquie, D. L. Mortensen, A. Intintoli, D. A. Hogue, G. Nakamura, P. Rancatore, P. Lester, M. D. Sadick, E. Filvaroff, P. J. Fielder, et al.
Binding Protein-3-Selective Insulin-Like Growth Factor I Variants: Engineering, Biodistributions, and Clearance
Endocrinology,
January 1, 2001;
142(1):
165 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|